CJ CheilJedang consensus picture on the KRX, analysts see stable earnings path

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 19:31.

CJ CheilJedang (KR7097950000) remains a mid-cap staple on the Korea Exchange, tracked closely by Seoul brokerages for its steady food and bio earnings. The Tuesday focus is the analyst consensus on the KRX-listed stock with current estimates for 2026 profitability, according to MarketScreener data.

What the brokers project

According to a MarketScreener consensus snapshot accessed on June 23, 2026, CJ CheilJedang is followed by around a dozen domestic and international analysts, most of whom rate the stock as neutral to positive, with price targets clustered moderately above the current KRX trading level. The compiled figures signal expectations of mid-single-digit revenue growth in the core food segment and a cautious recovery in the bio business over the next two fiscal years.

One recent Korean brokerage note, summarized by FnGuide, points to margin stabilization in processed foods helped by input cost normalization and disciplined pricing, which supports the view of a stable earnings path rather than a rapid growth story. The same data set indicates net profit projections for 2026 that are broadly in line with recent historical averages, suggesting muted volatility in fundamental metrics despite a more volatile broader KOSPI backdrop.

Consensus, valuation and KRX context

On valuation, CJ CheilJedang’s forward price-earnings multiple sits in the lower double digits based on the 2026 EPS consensus, positioning the shares at a discount to some larger Korean consumer staples peers such as the food units of CJ Group and rival conglomerate affiliates tracked on the KOSPI. This relative discount reflects the conglomerate structure and the exposure to the more cyclical bio and feed operations, which analysts describe as adding earnings variability compared with pure-play packaged food peers.

The Korea Exchange listing provides liquidity through the main KRX venue in Seoul, and the stock often trades in tandem with broader KOSPI consumer names when sentiment turns toward defensives in periods of semiconductor-led volatility. In recent weeks, Korean market commentary from local outlets such as Maeil Business Newspaper has highlighted a rotation into stable cash-flow generators, with CJ CheilJedang mentioned among food and beverage names seen as offering more predictable dividends and earnings than chip manufacturers.

The products behind the stock

CJ CheilJedang’s business is anchored in processed foods ranging from ready-made meals to sauces and condiments, with brands such as Bibigo dumplings sold in South Korea and exported to markets including the United States and Europe, according to the company’s English-language corporate profile. The group also operates bio, feed and food ingredients businesses, supplying amino acids and specialty proteins to global customers, which adds an industrial revenue stream alongside its consumer-facing portfolio.

Where the shares trade today

The CJ CheilJedang shares (KR7097950000) trade on the Korea Exchange in Seoul, with the latest available closing price around the mid-100,000 won range on KRX as of June 23, 2026, according to recent quote data from a Korean market portal.

Disclaimer: This article provides factual information on CJ CheilJedang and its shares and does not constitute investment advice or a recommendation to buy or sell any securities.